§ 21-2C-08. Identifying prescription drug products that create affordability challenges for Sta...
West's Annotated Code of MarylandHealth--GeneralEffective: June 1, 2020
Effective: June 1, 2020
MD Code, Health - General, § 21-2C-08
§ 21-2C-08. Identifying prescription drug products that create affordability challenges for State health care system and patients
(a) On or before December 31, 2021, the Board shall:
(b) Based on the information collected under subsection (a)(1) of this section and obtained through memoranda of understanding under subsection (a)(2) of this section, the Board, in consultation with the Stakeholder Council, shall adopt regulations to:
(c) The Board shall use the information collected under subsection (a)(1) of this section and obtained through memoranda of understanding under subsection (a)(2) of this section to identify prescription drug products that are:
Credits
Added by Acts 2019, c. 692, § 1, eff. July 1, 2019. Amended by Acts 2020, c. 425, § 1, eff. June 1, 2020.
MD Code, Health - General, § 21-2C-08, MD HEALTH GEN § 21-2C-08
Current through legislation effective through April 9, 2023, from the 2024 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
End of Document |